A nano-carrier made of a norbornene derived isoniazid copolymer is designed. In vitro cytotoxicity assay and renal clearance analysis clearly indicate that the newly designed nano-carrier is biocompatible in nature. This nano-carrier with a hydrazone linker is shown to be a promising reservoir with excellent performance for an efficient drug delivery system. Moreover, the system also offers an effective strategy and new modalities for the development of TB therapy.
No takes yet. Share an insight, caveat, or question.
Mane et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: